AUSTIN, Texas, April 9, 2026 /PRNewswire/ -- Choose Health, an at-home blood testing company specializing in liver and metabolic health, today announced the launch of the GLP-1 Health Monitoring ...
Use of GLP-1 receptor agonists continues to shift rapidly, with early April developments highlighting changes in pricing models, drug access, regulatory oversight and personalized care. Here are five ...
Your genetics might play a role in how well cutting-edge weight loss drugs like Ozempic and Zepbound will work for you, a new ...
BENTONVILLE, Ark. (KNWA/KFTA) — GLP-1 blood testing is now being offered at select Sam’s Club locations in Texas through a partnership with Babson Diagnostics. The companies say the GLP-1 Test Panel ...
Phenomix's MyPhenome test continues to demonstrate predictive accuracy in identifying which patients are most likely to respond to GLP-1 therapies such as semaglutide. Studies presented at Obesity ...
Me Research Institute, a nonprofit medical research organization, announced the publication of a study that identifies ...
AUSTIN, TX / ACCESS Newswire / January 29, 2026 / BetterWay™ blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, announced today ...
Accumulating scientific evidence and industry interest from Eli Lilly, Altimmune and startup Baseline Therapeutics is driving further research on the therapeutic potential of GLP-1 receptor agonists ...
For patients with type 2 diabetes, a new study reinforces the importance of adhering to a healthy lifestyle even when taking a glucagon-like peptide-1 (GLP-1) receptor agonist. Patients who combined a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results